SINGULAR GENOMICS SYSTEMS IN

SINGULAR GENOMICS SYSTEMS IN (OMIC)

$0.8596

-0.07

(-7.67%)

Market is closed - opens 7 PM, 08 Jun 2023

Insights on Singular Genomics Systems Inc

  • Vs ISRG

    In the last 1 year, Intuitive Surgical Inc has given 42.2% return, outperforming this stock by 114.6%

Performance

  • $0.80
    $0.97
    $0.86
    downward going graph

    6.98%

    Downside

    Day's Volatility :17.29%

    Upside

    11.08%

    downward going graph
  • $0.76
    $4.80
    $0.86
    downward going graph

    11.06%

    Downside

    52 Weeks Volatility :84.06%

    Upside

    82.08%

    downward going graph

Returns

PeriodSINGULAR GENOMICS SYSTEMS INSector (Health Care)Index (Russel 2000)
3 Months
-51.0%
2.1%
-5.8%
6 Months
-48.85%
-6.4%
-2.1%
1 Year
-72.37%
-1.4%
-7.8%
3 Years
-96.32%
25.7%
17.4%

Highlights

Market Capitalization
67.1M
Book Value
$3.34
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.12
Wall Street Target Price
1.95
Profit Margin
0.0%
Operating Margin TTM
-5948.71%
Return On Assets TTM
-18.69%
Return On Equity TTM
-33.17%
Revenue TTM
1.6M
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-24.0K
EBITDA
-94.1M
Diluted Eps TTM
-1.12
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.44
EPS Estimate Next Year
-1.4
EPS Estimate Current Quarter
-0.35
EPS Estimate Next Quarter
-0.38

Analyst Recommendation

Hold
    10%Buy
    50%Hold
    40%Sell
Based on 10 Wall street analysts offering stock ratings for SINGULAR GENOMICS SYSTEMS IN(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
5
5
5
Sell
4
4
4

Analyst Forecast

What analysts predicted

Upside of 126.85%

Current $0.86
Target $1.95

Technicals Summary

Sell

Neutral

Buy

Singular Genomics Systems Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
SINGULAR GENOMICS SYSTEMS IN
SINGULAR GENOMICS SYSTEMS IN
-11.33%
-48.85%
-72.37%
-96.32%
-96.32%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
4.17%
17.82%
42.25%
59.8%
95.15%
ResMed Inc.
ResMed Inc.
-4.6%
-0.09%
3.49%
36.33%
109.6%
Becton, Dickinson and Company
Becton, Dickinson and Company
-0.41%
1.61%
-2.89%
1.3%
9.0%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-5.69%
46.76%
9.43%
66.71%
263.26%
Alcon AG
Alcon AG
5.86%
16.84%
4.6%
25.97%
36.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
SINGULAR GENOMICS SYSTEMS IN
SINGULAR GENOMICS SYSTEMS IN
22.3
NA
NA
-1.44
-0.33
-0.19
0.0
3.34
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
85.58
85.58
3.27
5.47
0.11
0.07
0.0
32.01
ResMed Inc.
ResMed Inc.
37.9
37.9
1.74
6.52
0.24
0.12
0.01
26.77
Becton, Dickinson and Company
Becton, Dickinson and Company
46.1
46.1
2.31
12.2
0.07
0.03
0.01
90.44
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
46.91
46.91
4.06
7.69
0.22
0.13
0.0
37.42
Alcon AG
Alcon AG
112.11
112.11
NA
2.65
0.02
0.02
0.0
40.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
SINGULAR GENOMICS SYSTEMS IN
SINGULAR GENOMICS SYSTEMS IN
Hold
$67.1M
-96.32%
22.3
0.0%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$111.2B
95.15%
85.58
20.4%
ResMed Inc.
ResMed Inc.
Buy
$32.6B
109.6%
37.9
21.49%
Becton, Dickinson and Company
Becton, Dickinson and Company
Buy
$72.1B
9.0%
46.1
8.6%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$25.5B
263.26%
46.91
19.15%
Alcon AG
Alcon AG
Buy
$39.2B
36.63%
112.11
3.84%

Institutional Holdings

  • Deerfield Management Co

    8.96%
  • UBS Group AG

    6.53%
  • ARCH VENTURE CORP

    5.27%
  • BlackRock Inc

    4.93%
  • Perceptive Advisors LLC

    4.56%
  • FMR Inc

    2.95%

Company Information

singular genomics is a venture capital backed biotech company in la jolla, california. we foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. singular genomics is inventing at the forefront of genomics, one of the world’s fastest growing industries. we are located in the center of the biotech hub on the torrey mesa close to the pacific ocean and next door to prestigious institutions like the salk institute, scripps, sanford burnham, and ucsd. we offer free gym membership, 401k plan, competitive health benefits, flexible vacation, and equity incentives, so you can grow as the company grows. we are working to accelerate genomics for the advancement of science and medicine and are passionate about the potential of genomics for improving human health.

Organization
SINGULAR GENOMICS SYSTEMS IN
Employees
276
CEO
Mr. Andrew Spaventa
Industry
Healthcare

FAQs